Home Nutriband

Nutriband

In operation
Post-IPO Round
Pharmaceutical R&D Developer
Basic
Enterprise Profile

Basic Information

Nutriband is a company primarily engaged in contract research and development services for transdermal drug portfolios, as well as the manufacturing of transdermal, topical, and coated products. Our lead product is an abuse-deterrent fentanyl transdermal system, which we are developing to provide clinicians and patients with an extended-release transdermal fentanyl product for managing chronic pain requiring around-the-clock opioid therapy. It aims to help combat the opioid crisis by incorporating features designed to prevent the misuse and abuse of these fentanyl patches.
Nutriband, Inc.
Florida,United States of America
less than 15 people
January 01, 2012
support@nutriband.com

Enterprise Profile

Industrial Sector
New Drug Development CXO (Pharmaceutical Outsourcing Organization)
Technology
Biotechnology
Concept
Therapeutic Products # Pain
Application Scenarios
Innovative Drugs